Quantitative Systems Pharmacology for Rare Disease Drug Development.

Bai, Jane Pf; Wang, Jie; Zhang, Yifei; Wang, Lingshan; Jiang, Xiling

Bai, Jane Pf; Wang, Jie; Zhang, Yifei; Wang, Lingshan; Jiang, Xiling.

Afiliación

Bai JP; Office of Clinical Pharmacology, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland 20903, USA.
Wang J; Office of Clinical Pharmacology, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland 20903, USA.
Zhang Y; Office of Clinical Pharmacology, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland 20903, USA.
Wang L; Office of Clinical Pharmacology, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland 20903, USA.
Jiang X; Office of Clinical Pharmacology, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland 20903, USA.

J Pharm Sci ; 112(9): 2313-2320, 2023 09.

Article en En | MEDLINE | ID: mdl-37422281

Asunto(s)

Farmacología en Red; Farmacología; Estados Unidos; Humanos; Enfermedades Raras/tratamiento farmacológico; Modelos Biológicos; Desarrollo de Medicamentos; Descubrimiento de Drogas; Preparaciones Farmacéuticas

Palabras clave

Dose optimization; Quantitative systems pharmacology; Rare disease drug development

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Farmacología / Farmacología en Red Tipo de estudio: Prognostic_studies Límite: Humans País/Región como asunto: America do norte Idioma: En Revista: J Pharm Sci Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google